Experimental pasta as an innovative approach to cholesterol reduction in patients with metabolic syndrome, with and without major psychiatric disorders: A randomized controlled trial supported by in vitro validation

Abstract Background Elevated non-high-density lipoprotein cholesterol (non-HDL-C) is a significant risk factor for atherosclerotic cardiovascular diseases, particularly in individuals with metabolic syndrome (MetS) and major psychiatric disorders (MPDs), who may experience metabolic side effects of...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Enrico D’Ambrosio, Maria Favia, Marcello Greco Miani, Francesco Pappagallo, Laura De Mastro, Antonia Ianniello, Silvia Saltarelli, Maria Fiore, Giulia Napoletano, Rita Masellis, Agostino Di Ciaula, Mohamad Khalil, Elisa Lanza, Antonino Noto, Felice Ungaro, Gianluca Kikidis, Giulio Pergola, Piero Portincasa, Alessandro Bertolino, Precision Healthcare and Lifestyle Working Group, Antonio Rampino
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Cambridge University Press 2025-01-01
Rangatū:	European Psychiatry
Ngā marau:	antipsychotics hypercholesterolemia major psychiatric disorders metabolic syndrome psychopharmacological treatment
Urunga tuihono:	https://www.cambridge.org/core/product/identifier/S0924933825100576/type/journal_article
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!